FOR RELEASE ON SEPTEMBER 29, 2022 Rockville Centre, NY Solve Advisors, a market data platform provider for fixed income securities, today announced that it has acquired Lumesis. The Lumesis DIVER product suite is a leading municipal bond solution allowing clients to track primary and secondary municipal bond markets, support the new issue [...]
Lumesis Announces the Release of its Debt Analysis ToolAlfred Tam2022-09-16T12:07:01-04:00
FOR RELEASE ON SEPTEMBER 16, 2022 Stamford, Connecticut Download PDF Lumesis, home of the DIVER suite of muni-focused business and regulatory solutions, announced the release of its Debt Analysis tool and its integration with its Pricing Platform. “Partnering with our Public Finance and Municipal Advisor clients who continue to provide us [...]
Lumesis Adds Key Quantitative Metrics to its Pricing & Scales PlatformOlivia Durr2022-05-13T11:11:08-04:00
FOR RELEASE ON APRIL 22, 2022 Stamford, Connecticut Download PDF Lumesis, home of the DIVER suite of muni-focused business and regulatory solutions, announced key enhancements to its Pricing and Scales platform. “As adoption of the platform continues, our clients and prospects continue to be great partners, letting us know what more [...]
Lumesis Integrates ICE’s Tax-Exempt Municipal Yield Curve into its New Issue and Secondary Pricing ServicesShalmali Shahane2021-10-22T17:15:54-04:00
Lumesis, home of the DIVER platform, and ICE Data Services, which is part of Intercontinental Exchange, Inc. (NYSE: ICE), announced that the tax-exempt ICE Municipal Yield Curve and spreads for all underlying trades will be available to all Lumesis customers using the DIVER New Issue and Secondary Pricing services.
Lumesis Rule 15c2-12 ‘Reasonable Diligence’ Service for Competitive Deals to Include COVID-19 ReviewShalmali Shahane2021-10-22T17:19:52-04:00
Lumesis, home of the DIVER Underwriter platform, has announced that, effective immediately, it’s SEC Rule 15c2-12 pre-bid diligence for competitive deals will include a review of whether the POS includes language regarding COVID-19.